Aerogen will be attending the ENA 2026 Conference, taking place September 28 through October 1 in Phoenix, AZ, and we’d love for you to join us!
News and Events
This educational program provides a practical, evidence-informed overview of de-escalation strategies in the management of patients with acute respiratory illness in the hospital setting.
This clinical webinar provides a practical, case-based review of aerosol medication delivery in the emergency department (ED), presented from the perspective of an emergency physician.
Reaching over
0
Patients
In more than
0
Countries
With over
0
International Patents
And
0
Publications Related to Aerogen Technology
†Study performed in healthy subjects compared to jet nebulizer; between-group difference: 34.1% vs 5.2%; p<0.001
*Residual Volume is defined as the amount of medication left in the cup after a treatment.
- Aerogen Data on File.
- 2. 30-674 Rev P Aerogen Solo Instruction Manual
- Dugernier J, Hesse M, Vanbever R, et al. SPECT-CT comparison of lung deposition using a system combining a vibrating-mesh nebulizer with a valved holding chamber and a conventional jet nebulizer: a randomized cross-over study. Pharm Res. 2017;34(2):290-300.
-
Dunne RB, Shortt
S. Comparison of bronchodilator administration with vibrating mesh
nebulizer and standard jet nebulizer in the emergency department. Am J
Emerg Med. 2018;36(4):641-646.
- Lin HL, Fang TP, Cho HS, et al. Aerosol delivery
during spontaneous breathing with different types of nebulizers - in vitro/ex
vivo models evaluation. Pulmonary Pharmacology & Therapeutics; 2018; 48;
225-231
GL-3458-1-EN
